- 1) Giovannucci, E., Epidemiologic characteristics of prostate cancer. Cancer, 75 (Suppl), 1766–1777 (1995).
- 2) Chung, B.-C., Picado-Leonard, J., Haniu, M., Bienkowski, M., Hall, P. F., Shively, J. E., and Miller, W. L., Cytochrome P450c17(steroid 17α-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc. Natl. Acad. Sci. USA, 84, 407–411 (1987).
- 3) Jarman, M., Smith, H. J., Nicholls, P. J., and Simons, C., Inhibitors of enzymes of androgen biosynthesis: cytochrome P45017α and 5α-steroid reductase. Nat. Prod. Rep., 495–512 (1998).
- 4) Njar, V. C. O., and Brodie, A. M. H., Inhibitors of 17α-Hydroxylase/17,20-Lyase (CYP17): potential agents for the treatment of prostate cancer. Curr. Pharm. Des., 5, 163–180 (1999).
- 5) Hakki, T., and Bernhardt, R., CYP17- and CYP11B-dependent steroid hydroxylases as drug development targets. Pharmacol. Ther., 111, 27–52 (2006).
- 6) Sergejew, T., and Hartmann, R. W., Pyridyl substituted benzocycloalkenes: new inhibitors of 17α-hydroxylase/17,20-lyase (P450 17α). J. Enzyme Inhib., 8, 113–122 (1994).
- 7) Lee, B.-L., and Ong, C.-N., Comparative analysis of tea catechins and theaflavins by high-performance liquid chromatography and capillary electrophoresis. J. Chromatogr. A, 881, 439–447 (2000).
- 8) Muto, S., Fujita, K., Yamazaki, Y., and Kamataki, T., Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat. Res., 479, 197–206 (2001).
- 9) Jankun, J., Selman, S. H., Swiercz, R., and Skrzypczak-Jankun, E., Why drinking green tea could prevent cancer. Nature, 387, 561 (1997).
- 10) Chhabra, S. K., and Yang, C. S., Tea and prostate cancer. Epidemiol. Rev., 23, 106–109 (2001).
- 11) Gupta, S., Hastak, K., Ahmad, N., Lewin, J. S., and Mukhtar, H., Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. USA, 98, 10350–10355 (2001).
- 12) Bettuzzi, S., Brausi, M., Rizzi, F., Castagnetti, G., Peracchia, G., and Corti, A., Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res., 66, 1234–1240 (2006).
- 13) Zhou, J.-R., Yu, L., Zhong, Y., and Blackburn, G. L., Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J. Nutr., 133, 516–521 (2003).
- 14) Lee, H.-H., Ho, C.-T., and Lin, J.-K., Theaflavin-3,3′-digallate and penta-O-galloyl-β-D-glucose inhibit rat liver microsomal 5α-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells. Carcinogenesis, 25, 1109–1118 (2004).
- 15) Henning, S. M., Aronson, W., Niu, Y., Conde, F., Lee, N. H., Seeram, N. P., Lee, R.-P., Lu, J., Harris, D. M., Moro, A., Hong, J., Pak-Shan, L., Barnard, R. J., Ziaee, H. G., Csathy, G., Go, V. L. W., Wang, H., and Heber, D., Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J. Nutr., 136, 1839–1843 (2006).
- 16) Liao, S., and Hiipakka, R. A., Selective inhibition of steroid 5α-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem. Biophys. Res. Commun., 214, 833–838 (1995).
- 17) Bode, A. M., and Dong, Z., Signal transduction pathways: targets for green and black tea polyphenols. J. Biochem. Mol. Biol., 36, 66–77 (2003).
- 18) Satoh, K., Sakamoto, Y., Ogata, A., Nagai, F., Mikuriya, H., Numazawa, M., Yamada, K., and Aoki, N., Inhibition of aromatase activity by green tea extract catechins and their endocrinological effects of oral administration in rats. Food Chem. Toxicol., 40, 925–933 (2002).
- 19) Ideyama, Y., Kudoh, M., Tanimoto, K., Susaki, Y., Nanya, T., Nakahara, T., Ishikawa, H., Yoden, T., Okada, M., Fujikura, T., Akaza, H., and Shikama, H., Novel nonsteroidal inhibitor of cytochrome P45017α(17α-hydroxylase/C17-20 lyase), YM116, decreased prostatic weights by reducing serum concentrations of testosterone and adrenal androgens in rats. Prostate, 37, 10–18 (1998).
- 20) Fujiki, H., Suganuma, M., Imai, K., and Nakachi, K., Green tea: cancer preventive beverage and/or drug. Cancer Lett., 188, 9–13 (2002).
Full access
Inhibition of 17α-Hydroxylase/C17,20-Lyase (CYP17) from Rat Testis by Green Tea Catechins and Black Tea Theaflavins
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.